Schedule 13D ownership disclosure

CAMP4 Therapeutics Corp.

Security class unavailable · CUSIP: 13463J101

Event date: 2024-10-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,625,145
Percent of class
13.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-110570
Form type
SC 13D
Filer
5AM Ventures VI, L.P.
CIK
CIK 1753037
Filed
Oct 22, 2024
Reporting period
Oct 15, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub